Pamela Esposito insider trades

Open-market stock purchases and sales by Pamela Esposito, Unknown at Kymera Therapeutics, Inc, from SEC Form 4 filings since Jul 24, 2018.

Recent trades

DateStockTradeValue
Jun 24, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
May 19, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Mar 20, 2026KYMR Kymera Therapeutics, IncSold$54.4K
Mar 20, 2026KYMR Kymera Therapeutics, IncSold$47.5K
Mar 20, 2026KYMR Kymera Therapeutics, IncSold$95.9K
Mar 20, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Feb 20, 2026KYMR Kymera Therapeutics, IncSold$165K
Feb 20, 2026KYMR Kymera Therapeutics, IncSold$52.9K
Feb 20, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Jan 20, 2026KYMR Kymera Therapeutics, IncSold$26.7K
Jan 20, 2026KYMR Kymera Therapeutics, IncSold$333K
Jan 20, 2026KYMR Kymera Therapeutics, IncSold$13.7K
Jan 20, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Jan 20, 2026KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 17, 2025KYMR Kymera Therapeutics, IncSold$1.2M
Dec 17, 2025KYMR Kymera Therapeutics, IncSold$655K
Dec 17, 2025KYMR Kymera Therapeutics, IncSold$342K
Dec 17, 2025KYMR Kymera Therapeutics, IncSold$84.1K
Dec 17, 2025KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 17, 2025KYMR Kymera Therapeutics, IncBought (not open market)—
Dec 17, 2025KYMR Kymera Therapeutics, IncBought (not open market)—

Companies traded

  • KYMR Kymera Therapeutics, Inc: 16 sales, last Jun 24, 2026
  • REPL Replimune Group, Inc: 25 sales, last Sep 12, 2023

Get free alerts when Pamela Esposito files a new trade →